FDAnews
www.fdanews.com/articles/131376-ablexis-cuts-deal-with-pfizer-and-four-other-pharmas-for-discovery-tool

Ablexis Cuts Deal With Pfizer and Four Other Pharmas for Discovery Tool

October 26, 2010
Ablexis didn’t force its investors to wait very long to see some returns. The San Francisco-based biotech company announced Tuesday it has struck an unusual deal to provide its antibody drug discovery technology to five big drugmakers simultaneously, as an alternative way to generate returns without waiting around for the unlikely event of an IPO, or a lucrative company takeover.
Xconomy